SHP099 HCl
SHP099 is a potent, selective, orally bioavailable and potent SHP2 inhibitor with IC50 = 0.07 μM and p-ERK modulation in cells with IC50 = 0.250 μM. SHP099 exhibits dose-dependent pathway inhibition and antitumor activity in xenograft models.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0657 |
| Pricing | 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire |